Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Pacira BioSciences Inc (PCRX)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 18
  • 1 comments

(51% Neutral) PACIRA BIOSCIENCES, INC. (PCRX) Reports Profit for 2022-06-30

Comment Full text

Lexicon Pharmaceuticals Inc. (LXRX)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 18
  • 1 comments

(75% Positive) Lexicon Pharmaceuticals, Inc. (LXRX) Reports Net Loss for 2022-06-30

Comment Full text

Kura Oncology Inc (KURA)

  • Event
  • Aug. 03, 2022, 00:00 UTC
  • 17
  • 1 comments

(51% Neutral) KURA ONCOLOGY, INC. (KURA) Reports Net Loss for 2022-06-30

Comment Full text

Summit Plc (SMMT)

  • Event
  • Aug. 02, 2022, 21:09 UTC
  • 17
  • 1 comments

(10% Negative) Summit Therapeutics Inc. (SMMT) Announces Clinical Trial Timeline Adjustment

Comment Full text

Puma Biotechnology Inc (PBYI)

  • Event
  • Aug. 02, 2022, 20:47 UTC
  • 16
  • 1 comments

(99% Neutral) PUMA BIOTECHNOLOGY, INC. (PBYI) Announces New Board Appointment

Comment Full text

Apellis Pharmaceuticals Inc (APLS)

  • Event
  • Aug. 02, 2022, 20:38 UTC
  • 17
  • 1 comments

(99% Neutral) Apellis Pharmaceuticals, Inc. (APLS) Announces Business Combination

Comment Full text

Veracyte Inc (VCYT)

  • Event
  • Aug. 02, 2022, 20:15 UTC
  • 17
  • 1 comments

(30% Negative) VERACYTE, INC. (VCYT) Reports Q3 2022 Financial Results

Comment Full text

Ligand Pharmaceuticals Incorporated (LGND)

  • Event
  • Aug. 02, 2022, 20:10 UTC
  • 18
  • 1 comments

(99% Neutral) LIGAND PHARMACEUTICALS INC (LGND) Announces Executive Changes

Comment Full text

Gilead Sciences Inc (GILD)

  • Event
  • Aug. 02, 2022, 20:05 UTC
  • 17
  • 1 comments

(30% Negative) GILEAD SCIENCES, INC. (GILD) Reports Q3 2022 Financial Results

Comment Full text

Genmab (GMAB)

  • Event
  • Aug. 02, 2022, 19:08 UTC
  • 14
  • 1 comments

(99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

Comment Full text
  • Previous
  • 242
  • 243
  • 244
  • 245
  • 246
  • Next

Search

News categories

  • Technical Exchange News(11463)
  • Event(3265)
  • SEC News(213185)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(136986)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin